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ABSTRACT
Purpose: The UK Biobank is a large-scale biomedical
resource, containing sociodemographic and medical
information, including data on a previous diagnosis of
stroke or transient ischaemic attack (TIA). We
described these participants and their medication
usage.
Participants: We identified participants who either
self-reported or were identified from a nurse-led
interview, having suffered a stroke or a TIA and
compared them against participants without stroke ort
TIA. We assessed their risk factor burden (sex, age,
deprivation, waist to hip ratio (WHR), hypertension,
smoking, alcohol intake, diabetes, physical exercise
and oral contraception use (oral contraceptive pill,
OCP)) and medication usage.
Findings to date: We studied 502 650 people
(54.41% women), 6669 (1.23%) participants self-
reported a stroke. The nurse-led interview identified
7669 (1.53%) people with stroke and 1781 (0.35%)
with TIA. Hypertension, smoking, higher WHR, lower
alcohol consumption and diabetes were all more
common in people with cerebrovascular disease
(p<0.0001 for each). Women with cerebrovascular
disease were less likely to have taken the OCP
(p=0.0002). People with cerebrovascular disease did
more exercise (p=0.03). Antithrombotic medication
was taken by 81% of people with stroke (both self-
report and nurse-led responders) and 89% with TIA.
For self-reported stroke, 63% were taking
antithrombotic and cholesterol medications, 54%
taking antithrombotic and antihypertensive medications
and 46% taking all 3. For the nurse-led interview and
TIA, these figures were 65%, 54% and 46%, and 70%,
53% and 45%, respectively.
Future plans: The UK Biobank provides a large,
generalisable and contemporary data source in a young
population. The characterisation of the UK Biobank
cohort with cerebrovascular disease will form the basis
for ongoing research using this data source.
INTRODUCTION
The UK Biobank is a national health
resource, intended to improve the preven-
tion, diagnosis and treatment of illness.1 It
holds detailed demographic, social and
medical information, along with physical
measures, such as weight and blood pressure.
Participants gave consent to have their future
health records linked to their UK Biobank
data, a process which is ongoing.
There is comparatively little epidemio-
logical data on younger populations with
stroke.2 The UK Biobank obtained informa-
tion regarding previous stroke or transient
ischaemic attack (TIA) and commonly asso-
ciated medications (such as blood pressure
and lipid-lowering medications) in people
aged 40–69 years. It is an order of magnitude
larger than previous self-reported estimates
of cerebrovascular disease. We aimed to
describe the cohort of participants from the
UK Biobank who self-reported a diagnosis of
stroke and TIA. We aimed to describe the
medication data of the cohort.
Data collection and follow-up: Between 2006
and 2010, the UK Biobank collected detailed
data on 502 650 people. They used 22 assess-
ment centres based in England, Scotland
and Wales. Participants were recruited from
National Health Service (NHS) patient regis-
ters and contacted if they lived within a
reasonable proximity to an assessment
centre.3 4
Participants provided detailed demo-
graphic, socioeconomic and health-related
data via a touchscreen questionnaire, includ-
ing medication history. Participants then
underwent a range of physical assessment
measures, included repeated blood pressure
measurements, height and weight. Finally
participants provided blood, urine and saliva
samples which have been held in a purpose-
built central storage facility, in Stockport,
UK, for future analysis. These depletable
Strengths and limitations of this study
▪ These data represent a very large sample.
▪ This self-reported data needs additional clinical
correlation.
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samples are due to be characterised by a comprehensive
range of biomarkers by the end of 2015, but are cur-
rently not readily accessible.
One of the touchscreen questionnaire responses was
‘Has a doctor ever told you that you have any of the fol-
lowing conditions? (You can select more than one
answer)’. The possible touchscreen responses were
‘heart attack, angina, stroke, high blood pressure, none
of the above, prefer not to answer’.
Following the questionnaire, a nurse-led interview was
performed to address medical history in general. In
order to prompt the nurses conducting the question-
naire and improve accuracy, all responses from the
touchscreen questionnaire were ﬂagged to the study
nurse. Therefore, if a participant had selected ‘stroke’
from the touchscreen question listed above, then the
nurse would have been aware of this response when dis-
cussing medical history. The nurses also asked indivi-
duals directly about their medical history. Therefore, it is
possible that someone may not have responded posi-
tively to the touchscreen questionnaire question regard-
ing stroke but may have done so when asked later by the
study nurse about medical history. It is also during the
nurse-led questionnaire that participants would have
been identiﬁed as having a medical history of TIA, when
questioned about their medical history. Further detailed
information regarding conducting the nurse-led ques-
tionnaire can be found at the UK Biobank website.5
Participants were also asked to self-report via the
touchscreen questionnaire their medication history.
They were asked speciﬁcally if they regularly took ‘medi-
cation for cholesterol’ or ‘blood pressure medication’
and could answer positively for both responses.
During the nurse-led interview, all medications where
recorded as free text and subsequently grouped and
coded by UK Biobank. We extracted data on reported
antiplatelet or anticoagulant use. Any participant using
any single or combination of these drugs was categorised
as taking antithrombotic medication.
We also extracted demographic data concerning age,
sex and socioeconomic class, measured using the
Townsend scale.6 In order to select the most appropriate
potential risk factors for stroke, we used data from the
INTERSTROKE study7 and the American Heart
Associations’ Stroke Councils Scientiﬁc Statement
Oversight Committee guideline (AHA).8 Review of these
publications identiﬁed seven modiﬁable risk factors that
could accurately be reproduced from the UK Biobank.
These risk factors represent the majority of the modiﬁ-
able risk factors contributing to cerebrovascular disease.
From the INTERSTROKE study, we identiﬁed hyper-
tension, smoking, waist to hip ratio (WHR), regular
physical activity, diabetes mellitus and alcohol intake as
risk factors we could study. We could not include psycho-
logical factors, diet, cardiac causes and apolipoprotein
levels as the data were not available in comparable
format. From the AHA guideline, we also identiﬁed the
oral contraceptive pill (OCP). We used the same
deﬁnitions as INTERSTROKE and the AHA guideline as
far as possible; we deﬁned a self-reported history of
hypertension, smoking (current, ex or never), WHR
(divided into tertiles), moderate or strenuous activity for
more than 4 h/week and a self-reported history of dia-
betes mellitus. For women, a history of ever having taken
the OCP (yes or no).
Alcohol intake was based on the data recorded in the
UK Biobank (alcohol daily or almost daily, alcohol on 3
or 4 days/week, alcohol once or twice a week, alcohol
one to three times per month, special occasions only,
never drinkers and former drinkers).
We describe the characteristics of the whole popula-
tion and the population with stroke disease and TIA
using descriptive statistics. We compared characteristics
of patients who self-reported stroke, those with
nurse-reported stroke, and TIA against those who did
not using t tests for continuous variables and χ2 tests for
dichotomous variables. The statistical analysis was con-
ducted using STATAV.11 (Stata Corp).
Cerebrovascular findings to date
UK Biobank released data for use on 502 650 partici-
pants. Their average age was 56.52 years, (SD 8.09).
There were 273 468 women (54.41%) who were younger
than the men (56.35 years (SD 8.00) compared with
56.74 years (SD 8.20), p<0.0001). The mean Townsend
Index for all participants was −1.29 (SD 3.10).
More participants self-reported stroke during the
nurse-led interview (n=7669 (1.53%)) than on the
touchscreen questionnaire (n=6699 (1.33%)). TIA was
reported via the verbal questionnaire in 1781 (0.35%) of
participants. Patients self-reporting stroke and TIA were
older and more likely to be female (p<0.0001) in com-
parison to patients who did not. Higher levels of depriv-
ation were seen in people self-reporting cerebrovascular
disease via both the touchscreen and nurse-led question-
naire (p<0.0001), but this was not the case for reports of
TIA (p=0.13). The full results are shown in table 1.
The cardiovascular risk factors in patients self-
reporting stroke and TIA are shown in table 2 along
with patients who reported no stroke or TIA.
Self-reported hypertension was recorded in 27.01% of
the whole UK Biobank population. It was over 50% for
each of the patients with a history of self-reported
stroke, stroke from the nurse-led questionnaire and
TIA. People with any cerebrovascular history were more
likely to be former or current smokers. Diabetes was
reported in 5.25% of the UK Biobank population but
over 15% of patients with stroke and 10% of patients
with TIA. Each of these associations was signiﬁcant
(p<0.001, for each).
Self-reported alcohol intake was lower in people with
cerebrovascular disease in comparison to the population
without cerebrovascular disease. In people who drank
less than weekly, including never and former drinkers,
there was a higher proportion of cerebrovascular disease
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recorded (p<0.001) compared with those who drank
more frequently.
For women, there were 81.05% who had previously
taken the OCP. For self-reported stroke and nurse-led
stroke responses, these ﬁgures were 73.83% and 74.22%,
respectively (p<0.001), and for TIA, this ﬁgure was
75.55% (p=0.0002).
There were 23 823 (4.74%) people who reported
doing at least 4 or more hours of moderate or strenuous
physical exercise per week. Of the 303 897 people with
complete data for this response 302 (6.4%) of those who
had a previous stroke identiﬁed via the touchscreen
questionnaire responded positively to this question (vs
17 458 (5.84%), p=0.1, for those without a previous
stroke). For the nurse-led self-report question, these
ﬁgures were 357 (6.47%) and 23 463 (5.78%), p=0.03,
and for self-reported TIA, they were 91 (6.45%) vs
17 669 (5.84%), p=0.32.
In total, 76 397 (15.20%) people who were identiﬁed
as taking an antithrombotic medication, 104 028
(20.70%) of people self-reported as receiving a blood
pressure medication and 86 907 (17.29%) of people
self-reported receiving a cholesterol medication. For
each of these responses participants who reported
Table 1 Self-report for stroke and transient ischaemic attack (TIA) with demographics
Sex
Men Women Age (SD) Deprivation (SD)
Self-reported stroke via touchscreen questionnaire
Yes 6699 (1.33) 3983 (1.74) 2716 (0.99) 60.8 (6.78) −0.25 (3.54)
No 495 951 (98.67) 225 199 (98.26) 270 458 (99.01) 57.4 (6.78) −1.25 (3.11)
Self-reported stroke via nurse interview
Yes 7669 (1.53) 4516 (1.97) 3153 (1.15) 60.89 (6.73) −0.42 (3.48)
No 494 051 (98.29) 224 205 (97.83) 269 852 (98.68) 56.4 (8.09) −1.31 (3.08)
Missing (or not completed) 930 (0.19) 461 (0.2) 469 (0.17)
Self-reported TIA via nurse interview
Yes 1781 (0.35) 958 (0.42) 823 (0.3)) 62.19 (5.87) −1.31 (3.05)
No 499 939 (99.46) 227 763 (99.38) 272 176 (99.53) 57.19 (7.9) −1.22 (3.12)
Missing (or not completed) 930 (0.19 461 (0.2) 469 (0.17)
Number (%) 502 650 (100) 229 182 (100) 273 468 (100)
Table 2 Descriptive characteristics (p<0.001, unless stated)
Total UK
Biobank
Stroke diagnosed
by touchscreen
questionnaire
Stroke diagnosed
by nurse-led
questionnaire
Transient ischaemic
attack (nurse-led
questionnaire)
N=502 650 (100%) N=6699 N=7669 N=1781
Hypertension (self-reported) 135 787 (27.06) 3770 (56.34) 4257 (55.51) 912 (51.21)
Smoking
Current 52 989 (10.92) 1103 (16.48) 1223 (15.95) 191 (10.72)
Former 173 203 (34.52) 2851 (42.60) 3250 (42.38) 731 (41.04)
Never 275 565 (54.92) 2738 (40.91) 3196 (41.67) 859 (48.23)
Waist to hip ratio (tertiles)
Lowest NA 1181 (17.63) 1375 (17.93) 399 (22.4)
Middle NA 1987 (29.66) 2308 (30.10) 574 (32.23)
Highest NA 3470 (51.80) 3913 (51.02) 801 (44.97)
Self-report diabetes
Yes 26 408 (5.26) 1042 (15.57) 1151 (15.01) 178 (9.99)
Alcohol frequency
Daily or almost daily 101 794 (20.29) 1217 (18.19) 1437 (18.74) 389 (21.84)
3–4 times/week 115 459 (23.01) 1100 (16.44) 1280 (16.69) 340 (19.09)
1–2/week 129 325 (25.77) 1560 (23.31) 1800 (23.47) 406 (22.8)
Upto 3/month 55 871 (11.14) 713 (10.65) 821 (10.71) 200 (11.23)
Special occasions 58 032 (11.57) 1010 (15.09) 1132 (14.76) 233 (13.08)
Never 22 551 (4.49) 476 (7.11) 529 (6.9) 108 (6.06)
Former 18 115 (3.61) 597 (8.92) 651 (8.49) 104 (5.84)
Oral contraceptive pill (N=272 047)
Yes 220 501 (81.05) 1989 (73.83) 2326 (74.22) 621 (75.55) (p=0.002)
NA, not applicable.
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stroke or TIA disease all received more of these medica-
tions than the population as a whole, every response
was signiﬁcant (<0.0001). The full results are given
in table 3.
DISCUSSION
The objective of this study was to characterise the UK
Biobank participants with a history of stroke and TIA
and to gain insights into the treatment of patients at
population level in the UK.
There are surprisingly few studies documenting the
prevalence of stroke and TIA disease. For example, a
2012 review2 identiﬁed only ﬁve studies of stroke preva-
lence in the Western world. They estimated that for an
adult population, including older populations, the
prevalence of stroke ranged from 0.15% in Italy to
between 1.7% and 2.6% in the UK and the USA. When
these ﬁgures were assessed with respect to sex, there was
a suggestion that prevalence was higher in men. Age is
by far the largest non-modiﬁable risk factor for stroke
making the ﬁndings in our younger cohort (1.74% for
men and 0.99% for women) comparable.
Our ﬁndings noted a difference in reporting of preva-
lence between the self-reported and nurse-led ﬁgures
for cerebrovascular disease. There were 970 more
people identiﬁed with stroke disease following the
nurse-led questionnaire. Every person who responded
positively on the touchscreen questionnaire to having
stroke disease will have been challenged by the nurse
during the nurse-led interview. All of these people were
included in the nurse-led responses as having a stroke;
therefore, these data have been at least partially veriﬁed
by the nurse. The nurse also further identiﬁed people
with cerebrovascular disease via questions on medical
history. We would advocate that the ﬁgure (7669) is the
most accurate estimation of cerebrovascular disease
within the UK Biobank.
Reduced socioeconomic status was associated with
both self-reported and nurse-reported stroke and TIA.
Deprivation and stroke are associated with an increase in
mortality across a range of countries9 and also a Scottish
meta-analysis linked deprivation with stroke incidence
even after allowing for cardiovascular risk factors.10
However, our data are an order of magnitude larger
than the studies included in that review and add a con-
temporary UK-wide assessment of stroke and
deprivation.
When selecting the risk factors to study from the UK
Biobank, we attempted to use the risk factors charac-
terised in other studies. The advantages of this
approach are that the reproducibility of our study is
increased and our results can be compared directly to
those generated from the high-income countries
included in their studies. We were able to reproduce six
of the risk factors used in INTERSTROKE study and the
AHA guideline.
Hypertension was reported by 27% of the whole
cohort but in over 50% of the participants with cerebro-
vascular disease. These ﬁgures are consistent with other
epidemiological studies.11 Our ﬁndings reﬂect both the
causative effect of blood pressure and a heightened
awareness of hypertension treatment in stroke survivors.
Unsurprisingly, our results show an increased number of
current smokers and former smokers and a reduced rate
of never-smokers in those reporting cerebrovascular
disease.
UK Biobank WHR data can be closely compared with
the INTERSTROKE study data. This is because we were
able to conduct our analysis using tertiles and also
because while weight may have altered following a diag-
nosis of cerebrovascular disease, it is likely to be one of
the most challenging of modiﬁable risk factors to
change following diagnosis, although data on poststroke
weight change are sparse.12 In the INTERSTROKE
study, the incident rates were 23%, 33% and 43% for
the increasing tertiles of WHR. These results are com-
parable to our results for both self-reported TIA (22%,
33% and 45%, respectively) and stroke (18%, 30% and
51%). The high ﬁgure of 51% implies either an
increased weight gain following stroke or a lower preva-
lence of obesity in the INTERSTROKE study, which
included data from both high and low socioeconomic
countries.
Table 3 Medication history
Total UK
Stroke diagnosed
by touchscreen
Stroke diagnosed
by nurse-led
Transient
ischemic attack
Biobank questionnaire questionnaire
(nurse-led
questionnaire)
N=502 650 (100%) N=6699 N=7669 N=1781
Antithrombotic medications 76 397 (15.20) 5414 (80.82) 6243 (81.41) 1577 (88.55)
Cholesterol medications 86 907 (17.29) 4728 (70.58) 5466 (71.27) 1303 (73.16)
Blood pressure (BP) medications 104 027 (20.70) 4107 (61.31) 4681 (61.04) 996 (55.92)
Antithrombotic and cholesterol 45 525 (9.06) 4267 (63.70) 4958 (64.65) 1238 (69.51)
Antithrombotic and BP 42 650 (8.48) 3582 (53.47) 4107 (53.55) 930 (52.22)
Antithrombotic, cholesterol and BP 32 374 (6.44) 3063 (45.72) 3532 (46.06) 794 (44.58)
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The self-reported history of diabetes mellitus was
5.25%. For a cohort of middle aged, predominantly
Caucasian Europeans, this is what we would have antici-
pated.13 Estimates put diabetes prevalence between 10%
and 25% in people with existing cerebrovascular disease
depending on population and method used to diagnose
diabetes,14 and our results (15% for stroke and 10% for
TIA) compare closely to a self-reported diagnosis in a
young population.
Our results suggest that people who undertook at least
4 h of physical activity per week were more likely to have
had a cerebrovascular event. Four hours is a relatively
large amount and studies have consistently shown
beneﬁt in increased physical activity in reducing cerebro-
vascular disease.15 Our results are likely to be due to
reverse causation; either increased activity in cerebrovas-
cular sufferers to improve their general health or the
residual physical disability being reﬂected in normal
activities of daily living being deemed at least moderately
strenuous.
In people with cerebrovascular disease who drank
three times or more per month, their frequency of
drinking was below people without cerebrovascular
disease. Further, in people who have never drunk or no
longer drink, there was more cerebrovascular disease,
which may reﬂect either a reduced frequency of drink-
ing following diagnosis or an increased prevalence of
disease; the well-described ‘J-shaped curve’ of alcohol-
related illness.16
The OCP is associated with ischaemic stroke, particu-
larly at higher doses.17 18 We found that use of the oral
contraceptive was lower for our cerebrovascular out-
comes. Hence, it is possible that some of our partici-
pants with a medical history of cerebrovascular disease
were not prescribed the OCP, explaining the ﬁndings.
It is also possible that the result detected with cerebro-
vascular disease, physical activity, alcohol consumption
and OCP use reﬂects bias associated with the cross-
sectional nature of the data and this need to be a stated
limitation.
A high proportion of participants with self-reported
and nurse-reported stroke (81%) and TIA (89%) were
receiving an antithrombotic medication. The ﬁgure of
81% would seem appropriate for stroke, because up to
20% of people may have suffered intracerebral haem-
orrhage, thus restricting use and antithrombotic medi-
cation is not suitable for every individual. Our ﬁndings
compare favourably to the Post Stroke Rehabilitation
Outcome Project.19 Their study in 2005 of 1161
people with both ischaemic and haemorrhagic stroke
identiﬁed 62% of people as receiving antithrombotic
medication.
While stroke disease does appear to have appropriate
rates of antithrombotic prescription, TIA does appear to
be undertreated for antithrombotic medication. TIA is
almost exclusively a disease that results from infarction,
embolic or otherwise, rather than haemorrhage. While
antithrombotic will not be suitable for all of these people,
it is likely that 11% of untreated TIA disease represents
suboptimal management.
We also demonstrated that large numbers of positive
responders were taking cholesterol and blood pressure
medications, including combinations of these medica-
tions. Not all of these medications will be suitable for
each person with cerebrovascular disease; however, only
about 45% of participants were receiving all three medi-
cations, suggesting these medications are underpre-
scribed overall. Neither did we have information on
whether treatment targets had been adequately achieved
with these medications, something which is also likely to
be suboptimal.20 It is also likely that this young popula-
tion of healthy volunteer participants are more likely to
take and adhere to medication than less conscious
populations.
It is important to highlight what we have not done in
this study. First, we did not consider all of the well-
recognised risk factors in as much detail as possible, for
example, psychological disease. Smith et al21 recently
proposed criteria for probable major depression and
probable bipolar disorder within the UK Biobank.
Currently these criteria are not directly available from
UK Biobank. As these and other criteria become estab-
lished, researchers will be able to test hypotheses directly
between them and cerebrovascular disease in the UK
Biobank. Second, we only studied our exposure and
outcome variables in a comparatively simple form, when
other possible combinations could have been consid-
ered. For example, we recorded self-reported blood pres-
sure but blood pressure was also recorded at the
assessment visit. Neither did we perform detailed cross-
sectional analysis of each variable, such as smoking or
alcohol and in particular the pharmacotherapeutic data.
Both were conscious decisions. To have done so would
have been outside the remit of our objectives, which
were to provide an overview of the data. Each risk factor
would in itself form a separate detailed analysis.
Third, we have not looked at many of the known but
less well-established risk factors. There were two reasons
for not doing so. Often this was where the exact ques-
tion did not exist within the UK Biobank, for example,
recreational drug use. The second reason was where
clinical information was available it would be best
studied in relation to future linked data. For example,
will the people who self-reported an asymptomatic
carotid stenosis incur a different rate of incident cere-
brovascular disease? Finally and perhaps most import-
antly, these are self-reported data. As such it is likely that
it will underestimate the true prevalence of self-reported
and nurse-reported stroke disease, as well as TIA.
Despite the limitations of the data, this sample of half
a million people still represents the largest self-reported
estimate of cerebrovascular disease in a population of
this or any age. It adds to the available data on young
populations with self-reported stroke and TIA disease
which are less well described than older populations.
The clinical relevance of the data is to highlight that
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many people were not receiving all of the secondary pre-
vention medication that would have been expected.
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